Darryl Falzarano

9.6k total citations · 2 hit papers
69 papers, 5.2k citations indexed

About

Darryl Falzarano is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Darryl Falzarano has authored 69 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Animal Science and Zoology. Recurrent topics in Darryl Falzarano's work include SARS-CoV-2 and COVID-19 Research (36 papers), COVID-19 Clinical Research Studies (26 papers) and Viral Infections and Outbreaks Research (24 papers). Darryl Falzarano is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (36 papers), COVID-19 Clinical Research Studies (26 papers) and Viral Infections and Outbreaks Research (24 papers). Darryl Falzarano collaborates with scholars based in Canada, United States and Germany. Darryl Falzarano's co-authors include Vincent J. Munster, Emmie de Wit, Neeltje van Doremalen, Heinz Feldmann, Cynthia Martellaro, Dana Scott, Friederike Feldmann, Atsushi Okumura, Trenton Bushmaker and Angela L. Rasmussen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Darryl Falzarano

69 papers receiving 5.1k citations

Hit Papers

SARS and MERS: recent ins... 2013 2026 2017 2021 2016 2013 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SARS and MERS: recent insights into emerging coronaviruses
    2016 2.4k citations Emmie de Wit, Neeltje van Doremalen et al. profile →
  2. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
    2013 348 citations Darryl Falzarano, Emmie de Wit et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darryl Falzarano Canada 30 4.1k 690 686 652 617 69 5.2k
Neeltje van Doremalen United States 27 4.5k 1.1× 676 1.0× 662 1.0× 782 1.2× 806 1.3× 60 6.3k
Zhaohui Qian China 18 3.5k 0.9× 376 0.5× 913 1.3× 479 0.7× 716 1.2× 58 4.7k
Anastasia Gulyaeva Netherlands 12 4.0k 1.0× 346 0.5× 852 1.2× 719 1.1× 685 1.1× 21 5.7k
Doreen Muth Germany 22 4.2k 1.0× 609 0.9× 705 1.0× 381 0.6× 1.4k 2.3× 24 5.2k
Lisa E. Gralinski United States 30 4.1k 1.0× 627 0.9× 1.2k 1.8× 809 1.2× 834 1.4× 53 5.9k
Jian‐Piao Cai China 40 4.3k 1.1× 1.1k 1.6× 762 1.1× 687 1.1× 779 1.3× 148 5.7k
Xing‐Lou Yang China 27 4.2k 1.0× 477 0.7× 467 0.7× 456 0.7× 1.1k 1.8× 71 5.4k
Ronald Dijkman Switzerland 31 3.6k 0.9× 969 1.4× 600 0.9× 340 0.5× 1.0k 1.7× 73 4.9k
Ben Hu China 18 5.6k 1.4× 581 0.8× 955 1.4× 913 1.4× 1.1k 1.7× 34 7.5k
Shuofeng Yuan Hong Kong 33 4.4k 1.1× 982 1.4× 1.4k 2.0× 797 1.2× 473 0.8× 111 6.7k

Countries citing papers authored by Darryl Falzarano

Since Specialization
Citations

This map shows the geographic impact of Darryl Falzarano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Falzarano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Falzarano more than expected).

Fields of papers citing papers by Darryl Falzarano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Falzarano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Falzarano. The network helps show where Darryl Falzarano may publish in the future.

Co-authorship network of co-authors of Darryl Falzarano

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Falzarano. A scholar is included among the top collaborators of Darryl Falzarano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Falzarano. Darryl Falzarano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ostadgavahi, Ali Toloue, Rachelle Buchanan, Magen E. Francis, et al.. (2024). PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females. Scientific Reports. 14(1). 9854–9854. 6 indexed citations
2.
Francis, Magen E., Rachelle Buchanan, Kerry J. Lavender, et al.. (2023). Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2. Nature Communications. 14(1). 5990–5990. 2 indexed citations
3.
Jagoda, Evelyn, Davide Marnetto, Gayani Senevirathne, et al.. (2023). Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals. eLife. 12. 12 indexed citations
4.
Ndishimye, Pacifique, Rachelle Buchanan, Sabin Nsanzimana, et al.. (2023). Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load. iScience. 26(10). 107959–107959. 3 indexed citations
5.
Pringle, Eric S., Brett A. Duguay, Darryl Falzarano, et al.. (2023). A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition. Antiviral Research. 220. 105758–105758. 3 indexed citations
6.
Bhanumathy, Kalpana K., J. Lew, Anil Kumar, et al.. (2023). Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology. Viruses. 15(6). 1281–1281. 7 indexed citations
7.
Brumfield, Kyle D., Ken Lai, Darryl Falzarano, et al.. (2022). Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection. Viruses. 14(11). 2371–2371. 8 indexed citations
8.
Lew, J., et al.. (2022). SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model. Viruses. 14(10). 2272–2272. 4 indexed citations
9.
Scruten, Erin, Amanda Lang, J. Lew, et al.. (2022). High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection. Scientific Reports. 12(1). 9045–9045. 3 indexed citations
10.
Ostrov, David A., Andrew P. Bluhm, Kalpana K. Bhanumathy, et al.. (2021). Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens. 10(11). 1514–1514. 10 indexed citations
11.
12.
13.
Alharbi, Naif Khalaf, et al.. (2021). Immune Responses to MERS-CoV in Humans and Animals. Advances in experimental medicine and biology. 1313. 85–97. 1 indexed citations
14.
Falzarano, Darryl, et al.. (2021). Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Journal of Virology. 95(18). e0068721–e0068721. 31 indexed citations
15.
Li, Wei, Chuan Chen, Aleksandra Drelich, et al.. (2020). Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 117(47). 29832–29838. 52 indexed citations
16.
Doremalen, Neeltje van, Darryl Falzarano, Tianlei Ying, et al.. (2017). Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Research. 143. 30–37. 47 indexed citations
17.
Mehedi, Masfique, Thomas Hoenen, Shelly J. Robertson, et al.. (2013). Ebola Virus RNA Editing Depends on the Primary Editing Site Sequence and an Upstream Secondary Structure. PLoS Pathogens. 9(10). e1003677–e1003677. 47 indexed citations
18.
Wit, Emmie de, Angela L. Rasmussen, Darryl Falzarano, et al.. (2013). Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proceedings of the National Academy of Sciences. 110(41). 16598–16603. 234 indexed citations
19.
Falzarano, Darryl, Friederike Feldmann, Allen Grolla, et al.. (2011). Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus. The Journal of Infectious Diseases. 204(suppl_3). S1082–S1089. 45 indexed citations
20.
Falzarano, Darryl, Thomas W. Geisbert, & Heinz Feldmann. (2010). Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Review of Vaccines. 10(1). 63–77. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neeltje van Doremalen Breakdown of academic impact, for papers by Zhaohui Qian Breakdown of academic impact, for papers by Anastasia Gulyaeva Breakdown of academic impact, for papers by Doreen Muth Breakdown of academic impact, for papers by Lisa E. Gralinski Breakdown of academic impact, for papers by Jian‐Piao Cai Breakdown of academic impact, for papers by Xing‐Lou Yang Breakdown of academic impact, for papers by Ronald Dijkman Breakdown of academic impact, for papers by Ben Hu Breakdown of academic impact, for papers by Shuofeng Yuan
Rankless by CCL
2026